Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 3/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.45 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.35 |
| ▸ | FDPS | P14324 | 2/20 | 0.35 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6951123 | 0.93 | ALOX15 (0.80) | ALOX15ALDH1A1NFE2L2EPHX2USP2 | |
| SCHEMBL25990015 | 0.87 | ALOX15 (0.71) | ALOX15ALDH1A1NFE2L2EPHX2USP2 | |
| SCHEMBL6951114 | 0.87 | ALOX15 (0.71) | ALOX15ALDH1A1NFE2L2EPHX2USP2 | |
| SCHEMBL873576 | 0.87 | ALOX15 (0.71) | ALOX15ALDH1A1NFE2L2EPHX2USP2 | |
| SCHEMBL21051954 | 0.87 | ALOX15 (0.75) | ALOX15ALDH1A1NFE2L2EPHX2USP2 | |
| SCHEMBL25990030 | 0.86 | ALOX15 (0.69) | ALOX15ALDH1A1NFE2L2EPHX2USP2 | |
| SCHEMBL25990054 | 0.83 | ALOX15 (0.65) | ALOX15ALDH1A1NFE2L2EPHX2USP2 | |
| Citronellyl Acetate SCHEMBL20912959 | 0.83 | ALOX15 (1.00) | ALOX15ALDH1A1NFE2L2EPHX2USP2 | |
| Citronellyl Acetate SCHEMBL157075 | 0.83 | ALOX15 (1.00) | ALOX15ALDH1A1NFE2L2EPHX2USP2 | |
| Citronellyl Acetate SCHEMBL1866109 | 0.83 | ALOX15 (1.00) | ALOX15ALDH1A1NFE2L2EPHX2USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3720936-B1 | 3,7-DIMETHYLOCT-6-EN-1-YL METHYL CARBONATE AS PERFUME INGREDIENT | GIVAUDAN SA (CH) | 2024-08-14 | — | — | EP | disclosed |
| US-20230232831-A1 | MONOTERPENOID AND PHENYLPROPANOID CARBONATE ESTERS AND METHODS OF THEIR MAKING AND USE AS REPELLENTS | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. | 2023-07-27 | — | — | US | disclosed |
| US-20230232831-A1 | MONOTERPENOID AND PHENYLPROPANOID CARBONATE ESTERS AND METHODS OF THEIR MAKING AND USE AS REPELLENTS | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. | 2023-07-27 | — | — | US | disclosed |
| US-20200369981-A1 | ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2020-11-26 | — | — | US | disclosed |
| EP-3720936-A1 | ORGANIC COMPOUNDS | Givaudan SA (CH) | 2020-10-14 | — | — | EP | disclosed |
| WO-2019110690-A1 | ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2019-06-13 | — | — | WO | disclosed |
| US-5397689-A | Hydroquinone compound to prevent fogging, fading and color mixing with good solubility and preservability | FUJI PHOTO FILM CO., LTD. (JP) | 1995-03-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230232831-A1 | MONOTERPENOID AND PHENYLPROPANOID CARBONATE ESTERS AND METHODS OF THEIR MAKING AND USE AS REPELLENTS | CYP51A1, CYP17A1, CYP4A11 | ALOX15 56/4885ALDH1A1 813/4885NFE2L2 3358/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.